EU GMP Annex 11 Explained: What You Need to Know About Computerised Systems Compliance
Most organisations still think about GMP compliance mainly at go-live.
But regulatory risk does not usually sit at go-live anymore.
With the proposed revisions to Annex 11, including the strengthened focus on cybersecurity under Section 15, and the introduction of upcoming Annex 22 emphasising supplier oversight and governance, it is clear that expectations are evolving.
The conversation is gradually shifting.
It is no longer only about whether a system was validated.
It is about whether governance, security, supplier accountability, and evolving technologies remain defensible over time.
And increasingly, that includes AI.
Click on the button below to download the full Annex 11 & AI Readiness Diagnostic Soft File

Why a Traditional GMP Checklist May No Longer Be Sufficient
While Annex 11 revision remains in draft and draft Annex 22, the direction is clear:
- The regulated user remains accountable, even in cloud or vendor-managed models
- Cybersecurity is a GMP concern, not only an IT responsibility
- Supplier oversight must be demonstrable
- Systems must remain in a validated state throughout their lifecycle
- Governance must withstand upgrades, patches, and continuous release
Now add AI and advanced analytics into the mix.
Many organisations are:
- Exploring AI-assisted decision support
- Integrating predictive analytics into quality systems
- Automating risk classification or signal detection
- Using generative AI for documentation or review
However, few have formally assessed whether these deployments sit comfortably within a defensible GMP governance framework.
The Emerging Risk: AI Without Structured Governance
AI in regulated environments is not inherently non-compliant.The risk arises when:
- Model outputs influence GxP decisions without defined accountability
- Data integrity controls are assumed rather than demonstrated
- Change control does not consider model evolution or drift
- Cybersecurity impact of AI integrations is overlooked
- Supplier-provided AI capabilities lack structured oversight
Annex 11 and Annex 22 may not explicitly regulate “AI” as terminology, but they clearly regulate:
- Risk management
- System validation
- Data integrity
- Supplier accountability
- Security governance
AI must therefore be evaluated within these existing GMP expectations.

Introducing a Comprehensive GMP & AI Governance Diagnostic
To address this emerging gap, Tech Qualitas developed a structured diagnostic framework aligned to:
- Current Annex 11 requirements and proposed updates (including Section 15 cybersecurity focus)
- Proposed Annex 22 supplier and outsourcing oversight principles
- GxP system lifecycle governance
- AI and advanced analytics impact within regulated environments
This is not an audit. It is a structured evaluation across five critical governance domains
1
Governance & Accountability
- Clear ownership of GxP-impacting systems
- QA–IT–Security role clarity
- Decision traceability
2
Cybersecurity Alignment (Annex 11 Section 15 – Proposed Strengthening)
- Security controls affecting validated systems
- Patch and vulnerability governance
- Incident management integration
- Cloud and SaaS risk alignment
3
Supplier & Outsourcing Oversight (Annex 22 Principles)
- Vendor responsibility models
- Quality agreements
- Assessment of AI-enabled supplier tools
- Ongoing oversight mechanisms
4
AI & Advanced Analytics Controls
- Risk classification of AI-enabled functionality
- Validation approach for algorithm-driven features
- Data governance and integrity safeguards
- Change management for model updates
- Documentation and explainability considerations
5
Lifecycle Compliance Continuity
- Post–go-live governance
- Release impact assessments
- Evidence sustainability
- Inspection readiness
Why This Matters Now
Regulators are getting increasingly comfortable with:
- Cloud platforms
- SaaS delivery models
- Advanced analytics
- AI-assisted processes
But expectations remain firm regarding:
- Defined accountability
- Robust supplier oversight
- Cybersecurity governance
- Risk-based, defensible decision making
The question inspectors are increasingly exploring is not: “Do you use AI?”
It is: “How do you ensure it remains controlled within your GMP framework?”
Who Should Be Thinking About This
This diagnostic is particularly relevant for:
- SaaS-based GxP system providers
- Digital health platforms
- Pharma companies advancing cloud transformation
- Organisations integrating AI into quality or regulatory workflows
- GCCs managing global digital quality governance
The Strategic Shift
Validation alone is no longer the differentiator.
Governance maturity is.
Organisations that proactively assess:
- Cybersecurity governance under Annex 11 (current and proposed updates)
- Supplier oversight under draft Annex 22
- AI impact within GxP frameworks
will be better positioned for sustainable digital scale.
Those who wait for inspection pressure may find these discussions more difficult.
Final Thought
The future of GMP compliance is not about resisting AI or digital evolution.
It is about ensuring innovation remains defensible.
If your systems are evolving faster than your governance framework, it may be time to assess alignment proactively.